Sugammadex Olpha

Medicinal product

(Invented) name

Sugammadex Olpha

Active substance (s)

Sugamadeksas

Strength

100 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AB35, Sugammadex

Marketing authorisation holder

Olpha AS, Latvija

Date of authorisation

2026-10-02

Date of renewal

Documents

6163_pakuotes lapelis_2026-10-02.docx

6163_Sugammadex Olpha.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LV/H/0279/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml injekcinio tirpalo yra	1 ml
Sugamadeksas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122467	108577	1108577	flakonas	2 ml N1		Receptinis	LT/1/26/6163/001	Netiekiama	-	-	No	-	-
122468	108578	1108578	flakonas	2 ml N10		Receptinis	LT/1/26/6163/002	Netiekiama	-	-	No	-	-
122469	108579	1108579	flakonas	5 ml N1		Receptinis	LT/1/26/6163/003	Netiekiama	-	-	No	-	-
122470	108580	1108580	flakonas	5 ml N10		Receptinis	LT/1/26/6163/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-10-02	Registruotas